Demo Data from EDBT 2026 / reviewers in the wild / expert
Federica Miglietta
dblp:425/4043
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2024
—ORCID · unresolved
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
cancer genomics |
0.8 | 1 | 2024 | <tt>ALLSTAR</tt>: inference of reliAble causaL ruLes between Somatic muTAtions and canceR phenotypes · Bioinform. 2024 |
Bioinformatics and computational biology › cancer genomics
somatic mutation analysis |
0.8 | 1 | 2024 | <tt>ALLSTAR</tt>: inference of reliAble causaL ruLes between Somatic muTAtions and canceR phenotypes · Bioinform. 2024 |
Methods — techniques the papers use, named apart from their topics
protein-protein interaction network · 0.8multiple hypothesis testing correction · 0.8branch-and-bound · 0.8
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2024 | <tt>ALLSTAR</tt>: inference of reliAble causaL ruLes between Somatic muTAtions and canceR phenotypesabstractMOTIVATION: Recent advances in DNA sequencing technologies have allowed the detailed characterization of genomes in large cohorts of tumors, highlighting their extreme heterogeneity, with no two tumors sharing the same complement of somatic mutations. Such heterogeneity hinders our ability to identify somatic mutations important for the disease, including mutations that determine clinically relevant phenotypes (e.g. cancer subtypes). Several tools have been developed to identify somatic mutations related to cancer phenotypes. However, such tools identify correlations between somatic mutations and cancer phenotypes, with no guarantee of highlighting causal relations. RESULTS: We describe ALLSTAR, a novel tool to infer reliable causal relations between somatic mutations and cancer phenotypes. ALLSTAR identifies reliable causal rules highlighting combinations of somatic mutations with the highest impact in terms of average effect on the phenotype. While we prove that the underlying computational problem is NP-hard, we develop a branch-and-bound approach that employs protein-protein interaction networks and novel bounds for pruning the search space, while properly correcting for multiple hypothesis testing. Our extensive experimental evaluation on synthetic data shows that our tool is able to identify reliable causal relations in large cancer cohorts. Moreover, the reliable causal rules identified by our tool in cancer data show that our approach identifies several somatic mutations known to be relevant for cancer phenotypes as well as novel biologically meaningful relations. AVAILABILITY AND IMPLEMENTATION: Code, data, and scripts to reproduce the experiments available at https://github.com/VandinLab/ALLSTAR. Dario Simionato, Antonio Collesei, Federica Miglietta, Fabio Vandin |
Bioinform. | 3 |